School of Medicine, Iran University of Medical Science, Tehran, Iran.
Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
BMC Psychiatry. 2023 Feb 9;23(1):100. doi: 10.1186/s12888-023-04574-6.
Psychiatric disorders such as anxiety, depression, and traumatic stress are not rare during infectious outbreaks, as the COVID-19 pandemic has posed a great concern to the general population. In this study, we aimed to investigate whether experiencing psychiatric symptoms during COVID-19 is the result of the burden of carrying an illness or the COVID-19 itself.
Two hundred ten subjects and three different groups of participants (COVID-19 patients, university staff, and orthopedic patients) were recruited. They answered a demographic questionnaire, Yale-Brown Obsessive-Compulsive Scale (YBOCS) test for OCD symptoms, Impact of Event Scale-Revised (IES-R) for perceived trauma, Beck Anxiety Inventory (BAI) for anxiety, and Beck Depression Inventory (BDI) for depression assessments using phone or face-to-face interviews.
At least one OCD symptom was observed in 85.7% of the subjects. However, there was no significant difference between the 3 groups (p = 0.2194). Perceived trauma was significantly higher among COVID-19 patients followed by university staff and orthopedic patients (23.73, 16.21, 11.51 mean IES-R scores respectively, p = 8.449e). COVID-19 patients also showed higher anxiety (mean BAI score: 17.00) than the university staff and orthopedic patients' group (9.22 and 5.56 respectively) (p = 6.175e). BDI score did not show much variation for depression, the mean score was 9.66, 9.49, and 6.7 for the COVID-19 patients, university staff, and orthopedic patients respectively, (p = 0.2735).
Perceived trauma and anxiety symptoms are significantly higher in COVID-19 patients and the symptoms of OCD and depression do not differ between COVID-19 and non-COVID-19 people, so the necessity of screening and following treatment of patients with COVID-19 should be kept in mind.
IR.IUMS.FMD.REC.1399.761.
在传染病爆发期间,焦虑、抑郁和创伤后应激等精神障碍并不罕见,因为 COVID-19 大流行引起了公众的极大关注。在这项研究中,我们旨在探讨在 COVID-19 期间经历精神症状是疾病负担的结果还是 COVID-19 本身的结果。
招募了 210 名受试者和三组不同的参与者(COVID-19 患者、大学教职员工和骨科患者)。他们通过电话或面对面访谈回答了人口统计学问卷、耶鲁-布朗强迫症量表(YBOCS)测试强迫症症状、修订后的事件影响量表(IES-R)评估感知创伤、贝克焦虑量表(BAI)评估焦虑和贝克抑郁量表(BDI)评估抑郁。
至少有 85.7%的受试者出现了至少一种强迫症症状。然而,三组之间没有显著差异(p=0.2194)。COVID-19 患者的感知创伤明显更高,其次是大学教职员工和骨科患者(23.73、16.21、11.51 的平均 IES-R 评分,p=8.449e)。COVID-19 患者的焦虑程度也高于大学教职员工和骨科患者组(平均 BAI 评分:17.00)(p=6.175e)。BDI 评分对抑郁的变化不大,COVID-19 患者、大学教职员工和骨科患者的平均评分分别为 9.66、9.49 和 6.7(p=0.2735)。
COVID-19 患者的感知创伤和焦虑症状明显更高,而 COVID-19 和非 COVID-19 人群的强迫症和抑郁症状没有差异,因此应牢记对 COVID-19 患者进行筛查和后续治疗的必要性。
IR.IUMS.FMD.REC.1399.761。